Regarding the Eastern Cooperative Oncology (ECOG) performance status, a higher proportion of patients with FLT3-ITD AML had an ECOG score of 3–4 compared than those with wild-type FLT3 AML (6.9% vs. 1.9%, p=0.018). Here, FLT3 is linked to acute myeloid leukemia.